GlassScriptPhysician profile
Jaclyn Rieben
NPI 1972573988
$1,923.46
in general payments reported to CMS, 2019-2025
20 companies · $1,082 in 2025
The $1,082 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.04 · 2023: $15.22 · 2024: $802 · 2025: $1,082.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,756 · Education: $143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,756.44 |
| Education | $142.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $377.84 | 2024-2025 | Tremfya, Simponi, Simponi Aria |
| Abbvie INC. | $337.10 | 2024-2025 | |
| Genzyme Corporation | $250.82 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $214.86 | 2024-2025 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $169.52 | 2024-2025 | Sotyktu |
| Lilly USA, LLC | $150.34 | 2024-2025 | Ebglyss |
| Sun Pharmaceutical Industries INC. | $73.17 | 2024-2025 | |
| Organogenesis INC. | $60.75 | 2025 | Apligraf |
| Arcutis Biotherapeutics, INC. | $59.53 | 2024-2025 | Zoryve |
| Incyte Corporation | $37.36 | 2024-2025 | Opzelura |
| Stimlabs LLC | $26.02 | 2025 | Allacor P |
| Endo Pharmaceuticals INC. | $24.04 | 2021 | |
| Novartis Pharmaceuticals Corporation | $20.71 | 2024 | |
| Convatec INC. | $19.78 | 2024 | |
| Leo Pharma INC. | $19.71 | 2025 | Adbry |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $18.70 | 2025 | Nemluvio |
| Kerecis Limited | $17.80 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Ucb, INC. | $16.26 | 2024 | Bimzelx |
| Curonix LLC | $15.22 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pfizer INC. | $13.93 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaclyn Rieben listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.